Work

Supplementary Figure 3 from Targeting IGF-IR with Ganitumab Inhibits Tumorigenesis and Increases Durability of Response to Androgen-Deprivation Therapy in VCaP Prostate Cancer Xenografts

Year: 2023

Type: supplementary-materials

Abstract: PDF file - 151K, Assessment of phospho-AKT and total AKT in VCaP xenografts treated with combined androgen-deprivation therapy (castration) and ganitumab

DOI: 10.1158/1535-7163.22497694

Authors: Cale D. Fahrenholtz, Pedro J. Beltran, Kerry L. Burnstein

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362478573

Cites:

Cited by:

Related to: 10